Search results
Aurinia Pharmaceuticals Skids With Its Buyout Thesis Hanging By A Thread
Investor's Business Daily· 2 years agoAurinia Pharmaceuticals hired a trio of executives in a move that suggests it's nowhere near a...
Why Aurinia Pharmaceuticals Stock Is Slumping Today
Motley Fool· 9 months agoAurinia Pharmaceuticals (NASDAQ: AUPH), a company focused on developing treatments for autoimmune diseases, saw its share price fall by more than 5% in...
Aurinia Surges As It Explores 'Strategic Alternatives,' Including A Potential Buyout
Investor's Business Daily· 11 months agoAurinia Pharmaceuticals said it's exploring strategic alternatives, including a potential buyout,...
Aurinia (AUPH) Up on Paving the Way for a Potential Buyout
Zacks via Yahoo Finance· 11 months agoAurinia Pharmaceuticals AUPH rose almost 5.8% on Jun 30, as management announced that it is...
Why Shares of Aurinia Pharmaceuticals Soared This Week
Motley Fool· 1 year agoShares of Aurinia Pharmaceuticals (NASDAQ: AUPH) were up by 79.6% this week as of late Friday...
Aurinia (AUPH) Moves 13.3% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 2 years agoAurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The...
3 Stocks That Already Doubled in 2023 and Could Keep Climbing
Motley Fool· 1 year agoAre you looking for stocks that can deliver big gains in a short amount of time? If so, you may have...
3 Biotechs That Might Get Bought Out in 2023
Motley Fool· 1 year agoThis year, for example, Pfizer paid a whopping $43 billion for cancer drugmaker Seagen, Merck dished out nearly $11 billion for the inflammatory bowel...
AbbVie (ABBV) Buys Parkinson's Disease Treatment Maker
Zacks via Yahoo Finance· 8 months agoAbbVie's (ABBV) buyout of Mitokinin, which is making a novel treatment for Parkinson's Disease (PD),...
11 Oversold Biotech Stocks To Buy Right Now
Insider Monkey via Yahoo Finance· 3 months agoIn this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go...
